Fortrea Holdings Inc. FTRE · NASDAQ
$22.42 -0.31% (-$0.07)
Summary
28 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- Revenue fell by 1.4% a year over the last 3 years.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 1.4% a year over the last 3 years. For the next fiscal year analysts expect revenue to fall by 2.2%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $85.2M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 4
- Sell 1
Today's price within the analysts' price targets
The average target of $21.33 is 4.9% below today's price. 58% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Clinical Services Segment 100%
By region
- North America 47%
- Europe 31%
- Other Geographical Areas 21%
Clinical Services Segment brings in 100% of revenue.
Segments in detail